SEMA7A: Difference between revisions

Jump to navigation Jump to search
m (Robot: Automated text replacement (-{{SIB}} +, -{{EH}} +, -{{EJ}} +, -{{Editor Help}} +, -{{Editor Join}} +))
 
m (Robot: Automated text replacement (-{{reflist}} +{{reflist|2}}, -<references /> +{{reflist|2}}, -{{WikiDoc Cardiology Network Infobox}} +))
Line 62: Line 62:


==References==
==References==
{{reflist}}
{{reflist|2}}


==Further reading==
==Further reading==

Revision as of 14:33, 6 September 2012


Semaphorin 7A, GPI membrane anchor (John Milton Hagen blood group)
Identifiers
Symbols SEMA7A ; CD108; CDw108; H-SEMA-K1; H-Sema K1; H-Sema-L; JMH; MGC126692; MGC126696; SEMAK1; SEMAL
External IDs Template:OMIM5 Template:MGI HomoloGene2678
RNA expression pattern
File:PBB GE SEMA7A 210083 at tn.png
More reference expression data
Orthologs
Template:GNF Ortholog box
Species Human Mouse
Entrez n/a n/a
Ensembl n/a n/a
UniProt n/a n/a
RefSeq (mRNA) n/a n/a
RefSeq (protein) n/a n/a
Location (UCSC) n/a n/a
PubMed search n/a n/a

WikiDoc Resources for SEMA7A

Articles

Most recent articles on SEMA7A

Most cited articles on SEMA7A

Review articles on SEMA7A

Articles on SEMA7A in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on SEMA7A

Images of SEMA7A

Photos of SEMA7A

Podcasts & MP3s on SEMA7A

Videos on SEMA7A

Evidence Based Medicine

Cochrane Collaboration on SEMA7A

Bandolier on SEMA7A

TRIP on SEMA7A

Clinical Trials

Ongoing Trials on SEMA7A at Clinical Trials.gov

Trial results on SEMA7A

Clinical Trials on SEMA7A at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on SEMA7A

NICE Guidance on SEMA7A

NHS PRODIGY Guidance

FDA on SEMA7A

CDC on SEMA7A

Books

Books on SEMA7A

News

SEMA7A in the news

Be alerted to news on SEMA7A

News trends on SEMA7A

Commentary

Blogs on SEMA7A

Definitions

Definitions of SEMA7A

Patient Resources / Community

Patient resources on SEMA7A

Discussion groups on SEMA7A

Patient Handouts on SEMA7A

Directions to Hospitals Treating SEMA7A

Risk calculators and risk factors for SEMA7A

Healthcare Provider Resources

Symptoms of SEMA7A

Causes & Risk Factors for SEMA7A

Diagnostic studies for SEMA7A

Treatment of SEMA7A

Continuing Medical Education (CME)

CME Programs on SEMA7A

International

SEMA7A en Espanol

SEMA7A en Francais

Business

SEMA7A in the Marketplace

Patents on SEMA7A

Experimental / Informatics

List of terms related to SEMA7A

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]


Semaphorin 7A, GPI membrane anchor (John Milton Hagen blood group) (SEMA7A) also known as CD108 (Cluster of Differentiation 108), is a human gene.[1]

SEMA7A is a membrane-bound semaphorin that associates with cell surfaces via a glycosylphosphatidylinositol (GPI) linkage. SEMA7A is also known as the John-Milton-Hagen (JMH) blood group antigen, an 80-kD glycoprotein expressed on activated lymphocytes and erythrocytes.[supplied by OMIM][1]

See also

References

  1. 1.0 1.1 "Entrez Gene: SEMA7A semaphorin 7A, GPI membrane anchor (John Milton Hagen blood group)".

Further reading

  • Xu X, Ng S, Wu ZL; et al. (1998). "Human semaphorin K1 is glycosylphosphatidylinositol-linked and defines a new subfamily of viral-related semaphorins". J. Biol. Chem. 273 (35): 22428–34. PMID 9712866.
  • Lange C, Liehr T, Goen M; et al. (1998). "New eukaryotic semaphorins with close homology to semaphorins of DNA viruses". Genomics. 51 (3): 340–50. doi:10.1006/geno.1998.5256. PMID 9721204.
  • Yamada A, Kubo K, Takeshita T; et al. (1999). "Molecular cloning of a glycosylphosphatidylinositol-anchored molecule CDw108". J. Immunol. 162 (7): 4094–100. PMID 10201933.
  • Angelisová P, Drbal K, Cerný J; et al. (1999). "Characterization of the human leukocyte GPI-anchored glycoprotein CDw108 and its relation to other similar molecules". Immunobiology. 200 (2): 234–45. PMID 10416131.
  • Tamagnone L, Artigiani S, Chen H; et al. (1999). "Plexins are a large family of receptors for transmembrane, secreted, and GPI-anchored semaphorins in vertebrates". Cell. 99 (1): 71–80. PMID 10520995.
  • Mine T, Harada K, Matsumoto T; et al. (2000). "CDw108 expression during T-cell development". Tissue Antigens. 55 (5): 429–36. PMID 10885563.
  • Holmes S, Downs AM, Fosberry A; et al. (2002). "Sema7A is a potent monocyte stimulator". Scand. J. Immunol. 56 (3): 270–5. PMID 12193228.
  • Strausberg RL, Feingold EA, Grouse LH; et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMID 12477932.
  • Ota T, Suzuki Y, Nishikawa T; et al. (2004). "Complete sequencing and characterization of 21,243 full-length human cDNAs". Nat. Genet. 36 (1): 40–5. doi:10.1038/ng1285. PMID 14702039.
  • Gerhard DS, Wagner L, Feingold EA; et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)". Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMID 15489334.
  • Maurin JC, Delorme G, Machuca-Gayet I; et al. (2005). "Odontoblast expression of semaphorin 7A during innervation of human dentin". Matrix Biol. 24 (3): 232–8. doi:10.1016/j.matbio.2005.03.005. PMID 15907379.
  • Hu Y, Malone JP, Fagan AM; et al. (2006). "Comparative proteomic analysis of intra- and interindividual variation in human cerebrospinal fluid". Mol. Cell Proteomics. 4 (12): 2000–9. doi:10.1074/mcp.M500207-MCP200. PMID 16199891.
  • Koh JM, Oh B, Lee JY; et al. (2006). "Association study of semaphorin 7a (sema7a) polymorphisms with bone mineral density and fracture risk in postmenopausal Korean women". J. Hum. Genet. 51 (2): 112–7. doi:10.1007/s10038-005-0331-z. PMID 16372136.

External links

This article incorporates text from the United States National Library of Medicine, which is in the public domain.

Template:WH Template:WS